^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Ependymoma

Related cancers:
2d
Genome-wide profiling of lncRNAs in pediatric intracranial ependymomas identifies H19 as a novel pathogenic driver. (PubMed, Neurooncol Adv)
Finally, public data showed that H19 is more abundant in the EPN PF subgroup A, and that methylation of its imprinting control region (ICR) correlates strongly with better prognosis in EPN PF subgroup B (PFB). These findings suggest that H19 plays an oncogenic role in EPN and that the methylation status of its ICR may serve as a prognostic biomarker in PFB.
Journal
|
IGF2 (Insulin-like growth factor 2)
6d
Molecular Biology and Phase 1 Study of GM-CSF and Intrathecal Trastuzumab in Children with Recurrent Posterior Fossa Ependymoma. (PubMed, Neuro Oncol)
IT trastuzumab in combination with GM-CSF is safe in recurrent pediatric PF EPN. A larger phase 2 study that includes both recurrent PFA and RELA-ST EPN is needed to determine the long-term efficacy of this immunotherapy strategy.
P1 data • Journal • IO biomarker
|
HER-2 (Human epidermal growth factor receptor 2) • CSF2 (Colony stimulating factor 2) • RELA (RELA Proto-Oncogene)
|
Herceptin (trastuzumab)
10d
Cauda equina neuroendocrine tumors: An 11-Year retrospective report on clinicopathological characteristics and postoperative recurrence. (PubMed, Neurochirurgie)
CENETS are rare and often misdiagnosed. Serpentine dilated vessel identification at the tumor's cephalad part during surgery may be indicative, and gross total resection be curative.
Retrospective data • Journal
|
GATA3 (GATA binding protein 3) • SYP (Synaptophysin) • GFAP (Glial Fibrillary Acidic Protein) • OLIG2 (Oligodendrocyte Transcription Factor 2)
13d
Dominant clones leverage developmental epigenomic states to drive ependymoma. (PubMed, Nature)
In vivo lineage tracing studies identified neoplastic clones that aggressively dominated tumour growth and established the entire EPN cellular hierarchy. These findings identify developmental epigenomic states that are critical for fusion-oncoprotein-driven transformation and show how these states continue to shape tumour progression.
Journal
|
RELA (RELA Proto-Oncogene) • ZFTA (Zinc Finger Translocation Associated)
13d
PED-DNX2401: Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors (clinicaltrials.gov)
P2, N=39, Not yet recruiting, Clinica Universidad de Navarra, Universidad de Navarra | N=20 --> 39
Enrollment change
|
tasadenoturev (DNX-2401)
14d
Discovery of genetic susceptibility variants in pediatric and adult ependymoma. (PubMed, Neurooncol Adv)
Several significant intronic variants were harbored in genes associated with cancer and neurological disease. Future studies are needed to investigate the role of these age-specific alterations in ependymoma pathogenesis.
Journal
|
EDIL3 (EGF Like Repeats And Discoidin Domains 3)
22d
PNOC027: Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma (clinicaltrials.gov)
P=N/A, N=74, Recruiting, University of California, San Francisco | Trial primary completion date: Dec 2025 --> Dec 2027
Trial primary completion date
25d
PNOC041: Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma (clinicaltrials.gov)
P2, N=30, Recruiting, University of California, San Francisco | Not yet recruiting --> Recruiting
Enrollment open
|
metformin
25d
High frequency of mosaic NF2-related schwannomatosis diagnosed after somatic analysis of multi-nodular schwannomas in schwannomatosis patients. (PubMed, Hum Genet)
This study illustrates the underestimated high frequency of mosaic NF2-related schwannomatosis in patients harboring multi-nodular peripheral nerve schwannomas. As multi-nodular schwannomas are associated with higher surgical morbidity, the pivotal role of the NF2 gene in their tumorigenesis opens perspectives for Schwannomatosis research.
Journal
|
NF2 (Neurofibromin 2) • SMARCB1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily B, Member 1) • LZTR1 (Leucine Zipper Like Transcription Regulator 1)
27d
New P1/2 trial
|
tasadenoturev (DNX-2401)
28d
Adnexal Endometrioid Carcinomas With Sex Cord-Like Morphology are Frequently PAX8-Negative, SOX17-Positive, and Enriched for CTNNB1 Alterations. (PubMed, Am J Surg Pathol)
Most of these tumors are classified in the "no specific molecular profile" subgroup and have high rates of nuclear beta-catenin/CTNNB1 alterations. Awareness of these morphologic and immunohistochemical associations may help avoid misclassification as sex cord-stromal or other neoplasms.
Journal
|
TP53 (Tumor protein P53) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • SOX17 (SRY-Box Transcription Factor 17) • PAX8 (Paired box 8)
28d
Trial primary completion date
|
Opdivo (nivolumab) • temozolomide